香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 NEW CHINA LIFE INSURANCE COMPANY LTD. 01336 2025年前三季度業績預增公告 新華人壽保險股份有限公司（「本公司」）根據《證券及期貨條例》（香港法例第571章）第 XIVA部項下的內幕消息條文及《香港聯合交易所有限公司證券上市規則》第13.09條及 13.10B條，做出本公告。 一、本期業績預告情況 （一）業績預告期間：2025年1月1日至2025年9月30日。 （二）業績預告情況：經本公司初步測算，本公司2025年前三季度實現歸屬於母公司 股東的淨利潤預計為299.86億元至341.22億元（人民幣，下同），與2024年同期 相比，預計增加93.06億元至134.42億元，同比增長45%至65%；本公司2025年 前三季度實現歸屬於母公司股東的扣除非經常性損益的淨利潤預計為289.98億 元至331.41億元，與2024年同期相比，預計增加82.85億元至12 ...

二、新华人寿保险股份有限公司应按照有关规定及时办理变更及许可证换领事宜。 一、同意新华人寿保险股份有限公司陈仓营销服务部将营业场所变更为：陕西省宝鸡市陈仓区公园路1 号院2幢房屋2层1-6号。 2025年9月30日，国家金融监督管理总局宝鸡监管分局发布批复称，《新华人寿保险股份有限公司陕西 分公司关于陈仓营销服务部变更营业场所的请示》（新保陕字〔2025〕97号）收悉。经审核，现批复如 下： ...

Core Viewpoint - Xinhua Insurance's stock price has shown fluctuations, with a year-to-date increase of 28.78% and a recent decline over the past 20 days, indicating mixed market sentiment towards the company [1]. Financial Performance - As of June 30, Xinhua Insurance reported a net profit of 14.799 billion yuan, representing a year-on-year growth of 33.53% [2]. - The company has distributed a total of 35.939 billion yuan in dividends since its A-share listing, with 13.913 billion yuan distributed over the past three years [3]. Shareholder Information - The number of shareholders decreased by 15.88% to 61,000 as of June 30, while the average number of circulating shares per person increased by 18.96% to 34,325 shares [2]. - Hong Kong Central Clearing Limited is the fourth largest circulating shareholder, holding 60.5095 million shares, an increase of 6.6977 million shares from the previous period [3]. Stock Market Activity - On October 13, Xinhua Insurance's stock price fell by 2.01% to 61.44 yuan per share, with a trading volume of 758 million yuan and a turnover rate of 0.59% [1]. - The stock experienced a net outflow of 60.0765 million yuan in principal funds, with significant selling pressure observed [1].

每经AI快讯，10月13日，港股内险股全线走低，截至发稿，新华保险(01336.HK)跌3.77%，报45.98港 元；中国财险(02328.HK)跌3.1%，报17.79港元；中国太保(02601.HK)跌2.93%，报30.48港元；中国人寿 (02628.HK)跌2.54%，报21.5港元。 ...

Investment Rating - The report maintains a "Positive" investment rating for the industry [9] Core Insights - The upcoming Q3 reports are expected to show continued high growth in brokerage performance, enhancing the sector's allocation value. The insurance sector reflects a trend of deposit migration, increased equity allocation, and improved new policy costs, leading to a higher certainty of long-term ROE improvement and accelerated valuation recovery. Overall, the cost-effectiveness of allocations is gradually increasing [2][6] - Recommendations include companies with stable profit growth and dividend rates such as Jiangsu Jinzu, China Ping An, and China Pacific Insurance, as well as firms with significant advantages in business models and market positions [6] - The report recommends specific stocks including Xinhua Insurance, China Life, Hong Kong Stock Exchange, CITIC Securities, Dongfang Wealth, Tonghuashun, and Jiufang Zhitu Holdings based on performance elasticity and valuation levels [2][6] Market Performance - The non-bank financial index increased by 0.5% last week, with a relative excess return of +1.0% compared to the CSI 300, ranking in the middle of the industry [7] - Year-to-date, the non-bank financial index has risen by 7.4%, but with a relative excess return of -9.9% compared to the CSI 300, indicating a lower ranking [7] - The average daily trading volume in the market has increased to 26,029.82 billion yuan, up 18.98% week-on-week, with a daily turnover rate of 2.71%, up 42.99 basis points [7] Key Industry News & Company Announcements - The China Banking and Insurance Regulatory Commission issued a notice on strengthening the regulation of non-auto insurance business [8] - China Pacific Insurance's Chief Actuary Zhang Yuanhan has resigned [8]

Investment Rating - The report maintains an "Overweight" rating for the non-bank financial industry [1] Core Insights - The report highlights the regulatory push for high-quality development in health insurance and the implementation of "reporting and operation integration" in non-auto insurance, which is expected to improve industry profitability [1][4] Summary by Sections Non-Bank Financial Subsector Performance - In the recent two trading days (October 9-10, 2025), all non-bank financial sub-sectors outperformed the CSI 300 index, with the securities sector rising by 0.55%, insurance by 0.72%, and diversified finance by 1.68%, while the overall non-bank financial sector increased by 0.71% [9][10] Non-Bank Financial Subsector Views Securities - Trading volume has increased year-on-year, with the average daily trading volume for October 2025 reaching CNY 30,222 billion, a 35.10% increase compared to October 2024 [14] - The margin trading balance as of October 9, 2025, was CNY 24,455 billion, up 58.00% year-on-year [14] - The average price-to-book (PB) ratio for the securities industry is projected at 1.4x for 2025 [19] Insurance - The regulatory body has issued guidelines to promote high-quality development in health insurance, aiming for a multi-tiered health insurance market by 2030 [21] - Health insurance premiums totaled CNY 7,598 billion from January to August 2025, reflecting a 2.4% year-on-year growth [25] - The implementation of "reporting and operation integration" in non-auto insurance is expected to enhance profitability, with total premiums for non-auto insurance reaching CNY 6,195 billion, accounting for 50.8% of total premiums [24] Diversified Finance - The trust industry saw its asset scale reach CNY 29.56 trillion by the end of 2024, a 23.58% increase year-on-year, although profits declined significantly [32] - The futures market recorded a trading volume of 839 million contracts and a turnover of CNY 65.08 trillion in August 2025, marking year-on-year increases of 13.98% and 21.38%, respectively [35] Industry Ranking and Key Company Recommendations - The report ranks the insurance sector highest, followed by securities and diversified finance, recommending companies such as China Ping An, New China Life, China Pacific Insurance, CITIC Securities, Tonghuashun, and Jiufang Zhitu Holdings [48]

Investment Rating - The report maintains a positive outlook on the non-bank financial sector, indicating an "Overweight" rating for the industry, suggesting it will outperform the overall market [4][55]. Core Insights - The report highlights strong growth in the brokerage sector, with a significant increase in new A-share accounts and trading volumes, indicating a robust market environment. The net profit for the brokerage sector is expected to show high year-on-year growth for the first nine months of 2025 [4]. - The insurance sector is undergoing regulatory changes aimed at improving profitability, particularly in non-auto insurance, which is expected to benefit leading companies in the industry [4]. - The report identifies three main investment themes in the brokerage sector: 1) Stronger institutions benefiting from improved competition, 2) Brokerages with high earnings elasticity, and 3) Companies with strong international business capabilities [4]. Market Review - The Shanghai Composite Index rose by 1.47% during the period from September 29 to October 10, 2025, while the non-bank index increased by 3.18%. The brokerage sector saw a rise of 4.42%, while the insurance sector increased by 0.89% [7]. - The average daily trading volume for the Shanghai and Shenzhen stock exchanges reached 26,034.09 billion yuan, reflecting a year-on-year increase of 56.08% [15][31]. Non-Bank Industry Data - As of October 10, 2025, the financing balance in the margin trading market was 24,455.47 billion yuan, showing a year-on-year increase of 31.2% [15]. - The report notes that the average daily trading volume for the first nine months of 2025 was 26,034.09 billion yuan, indicating a vibrant trading environment [31]. Regulatory Developments - The Financial Regulatory Bureau has implemented a new framework for non-auto insurance, focusing on improving underwriting profitability and establishing stricter fee management and compliance measures [4][17]. - The report mentions the central bank's liquidity measures, including significant net injections through various monetary policy tools, which aim to maintain market liquidity [16][19].

Investment Rating - The report maintains a "Positive" outlook on the non-bank financial sector [1] Core Views - The report highlights a continuation of strong growth in the brokerage sector, with a significant increase in net profits expected for the first nine months of 2025. Key metrics include a 61% year-on-year increase in new A-share accounts and a 203% increase in average daily stock trading volume in September 2025 [2][5] - The brokerage sector is currently undervalued, with a price-to-book (PB) ratio of 1.48, placing it in the 47.8th percentile over the past decade [2] - The report notes a favorable market environment supporting continued high growth in brokerage performance, with specific recommendations for leading firms and those with strong international business capabilities [2][7] Summary by Sections Market Review - The Shanghai Composite Index rose by 1.47% during the period from September 29 to October 10, 2025, while the non-bank index increased by 3.18%. The brokerage, insurance, and diversified financial sectors reported gains of 4.42%, 0.89%, and 0.52%, respectively [5][6] Non-Bank Sector Insights - The report indicates that the insurance sector is benefiting from the implementation of a "de-involution" policy framework for non-auto insurance, which is expected to improve underwriting profitability for leading firms [2][16] - Specific investment recommendations include firms that are expected to benefit from improved competitive dynamics and those with strong earnings elasticity [2][7] Key Data Tracking - As of October 10, 2025, the average daily trading volume in the stock market was 26,034.09 billion yuan, reflecting an 18.99% increase from the previous period [14][32] - The report also tracks significant metrics such as the balance of margin financing and securities lending, which stood at 24,455.47 billion yuan as of October 9, 2025, marking a 31.2% increase from the end of 2024 [14][39]

（来源：四大新鲜事儿） 来源：四大新鲜事儿 2025年10月9日，河北省招标投标公共服务平台发布了《新华人寿保险股份有限公司客户经营管理赋能销售咨询项目中标候选人公示》。公告显示，该项 目第一中标候选人：毕马威企业咨询（中国）有限公司；投标总价：3,188,965.1元。 详细如下： 第一中标候选人：毕马威企业咨询（中国）有限公司；投标总价（不含税 元）：集中咨询服务费：￥3,066,037.74 ；陪跑落地服务费：￥122,927.36 ； | 河北省招标投标公共服务平台 | Hebei Province Bidding Public Service Platform | 一一公告发布指定媒介 -- | | --- | --- | --- | | 首页 | 统一注册 公告公示 京津专区 主体资信 违规公示 政策法规 专家服务 行政监督 交易保障 | (C) 0311-66635550/66635551 | | ♀ 您的当前位置：首页 > 京津专区 | | | 招标单位：新华人寿保险股份有限公司 招标代理：中化商务有限公司 项目名称：客户经营管理赋能销售咨询项目 项目编号：0747-2560SCCZC754 ...

Investment Rating - The report maintains an "Overweight" rating for the health insurance industry, indicating a positive outlook compared to the overall market performance [6][12]. Core Insights - The recent "Guiding Opinions on Promoting the High-Quality Development of Health Insurance" released by the regulatory authority marks a significant policy support for the health insurance sector, suggesting a favorable environment for growth [3][4]. - The report identifies four major categories of health insurance products: commercial medical insurance, long-term care insurance, disability income loss insurance, and critical illness insurance, each with specific development policies [4][5]. - The integration of health insurance with health management and the health industry is emphasized, promoting a comprehensive service system that includes prevention, management, and coverage [4]. - The report highlights the potential for health insurance products to experience a second wave of growth due to low interest rates and healthcare reforms, with commercial medical insurance expected to become a key product [6][7]. Summary by Sections Health Insurance Product Categories - The report categorizes health insurance into four types: 1. Commercial medical insurance: Actively developed with a focus on comprehensive coverage and risk matching 2. Long-term care insurance: Strongly promoted, emphasizing cash benefits and care services 3. Disability income loss insurance: Strongly promoted with an expanded coverage base 4. Critical illness insurance: Steadily developed with updates based on disease spectrum changes [4]. Policy Support and Innovations - The report outlines new policy measures, including: 1. Allowing well-rated insurers to offer dividend-type long-term health insurance 2. Supporting personal account-based long-term medical insurance 3. Encouraging innovative collaborations between insurance and pharmaceutical companies 4. Promoting group health insurance development [5]. Market Outlook - The report anticipates that health insurance products will benefit from a combination of low interest rates and evolving customer needs, leading to increased focus on protection-oriented products [6][7]. - Key companies recommended for investment include China Life, New China Life, China Pacific Insurance, China Ping An, and Sunshine Insurance, with a suggestion to pay attention to China Taiping [6].